Variability in Genome Editing Outcomes: Challenges for Research Reproducibility and Clinical Safety

Overview

Journal Mol Ther

Publisher Cell Press

Specialties Molecular Biology
Pharmacology

Date 2020 Apr 4

PMID 32243835

Citations 21

Authors

Lydia Teboul

Yann Herault

Sara Wells

Waseem Qasim

Guillaume Pavlovic

Affiliations

Soon will be listed here.

Abstract

Genome editing tools have already revolutionized biomedical research and are also expected to have an important impact in the clinic. However, their extensive use in research has revealed much unpredictability, both off and on target, in the outcome of their application. We discuss the challenges associated with this unpredictability, both for research and in the clinic. For the former, an extensive validation of the model is essential. For the latter, potential unpredicted activity does not preclude the use of these tools but requires that molecular evidence to underpin the relevant risk:benefit evaluation is available. Safe and successful clinical application will also depend on the mode of delivery and the cellular context.

Citing Articles

Applications of Gene Editing and Nanotechnology in Stem Cell-Based Therapies for Human Diseases.

Bolideei M, Barzigar R, Gahrouei R, Mohebbi E, Haider K, Paul S Stem Cell Rev Rep. 2025; .

PMID: 40014250 DOI: 10.1007/s12015-025-10857-0.

High throughput functional profiling of genes at intraocular pressure loci reveals distinct networks for glaucoma.

Greatbatch C, Lu Q, Hung S, Barnett A, Wing K, Liang H Hum Mol Genet. 2024; 33(9):739-751.

PMID: 38272457 PMC: 11031357. DOI: 10.1093/hmg/ddae003.

A Fluorescent Reporter Mouse for Assessment of Genome Editing with Diverse Cas Nucleases and Prime Editors.

Chen Z, Kwan S, Mir A, Hazeltine M, Shin M, Liang S CRISPR J. 2023; 6(6):570-582.

PMID: 38108517 PMC: 10753986. DOI: 10.1089/crispr.2023.0048.

Correspondence of Yolk Sac and Embryonic Genotypes in F0 Mouse CRISPants.

Fuselier K, Kruger C, Salbaum J, Kappen C Med Res Arch. 2023; 11(6).

PMID: 37885852 PMC: 10601497. DOI: 10.18103/mra.v11i6.3989.

Hidden prevalence of deletion-inversion bi-alleles in CRISPR-mediated deletions of tandemly arrayed genes in plants.

Liu J, Wang F, Li C, Li Y, Li J Nat Commun. 2023; 14(1):6787.

PMID: 37880225 PMC: 10600118. DOI: 10.1038/s41467-023-42490-1.

References

Lynch M . Evolution of the mutation rate. Trends Genet. 2010; 26(8):345-52. PMC: 2910838. DOI: 10.1016/j.tig.2010.05.003. View

Ledford H . Quest to use CRISPR against disease gains ground. Nature. 2020; 577(7789):156. DOI: 10.1038/d41586-019-03919-0. View

Wang M, Glass Z, Xu Q . Non-viral delivery of genome-editing nucleases for gene therapy. Gene Ther. 2016; 24(3):144-150. DOI: 10.1038/gt.2016.72. View

Shrivastav M, De Haro L, Nickoloff J . Regulation of DNA double-strand break repair pathway choice. Cell Res. 2007; 18(1):134-47. DOI: 10.1038/cr.2007.111. View

Cyranoski D, Ledford H . Genome-edited baby claim provokes international outcry. Nature. 2018; 563(7733):607-608. DOI: 10.1038/d41586-018-07545-0. View

Pickar-Oliver A, Gersbach C . The next generation of CRISPR-Cas technologies and applications. Nat Rev Mol Cell Biol. 2019; 20(8):490-507. PMC: 7079207. DOI: 10.1038/s41580-019-0131-5. View

Pattanayak V, Lin S, Guilinger J, Ma E, Doudna J, Liu D . High-throughput profiling of off-target DNA cleavage reveals RNA-programmed Cas9 nuclease specificity. Nat Biotechnol. 2013; 31(9):839-43. PMC: 3782611. DOI: 10.1038/nbt.2673. View

Tebas P, Stein D, Tang W, Frank I, Wang S, Lee G . Gene editing of CCR5 in autologous CD4 T cells of persons infected with HIV. N Engl J Med. 2014; 370(10):901-10. PMC: 4084652. DOI: 10.1056/NEJMoa1300662. View

Mehta A, Haber J . Sources of DNA double-strand breaks and models of recombinational DNA repair. Cold Spring Harb Perspect Biol. 2014; 6(9):a016428. PMC: 4142968. DOI: 10.1101/cshperspect.a016428. View

10.

Normile D . China sprints ahead in CRISPR therapy race. Science. 2017; 358(6359):20-21. DOI: 10.1126/science.358.6359.20. View

11.

Hruscha A, Krawitz P, Rechenberg A, Heinrich V, Hecht J, Haass C . Efficient CRISPR/Cas9 genome editing with low off-target effects in zebrafish. Development. 2013; 140(24):4982-7. DOI: 10.1242/dev.099085. View

12.

Renaud J, Boix C, Charpentier M, De Cian A, Cochennec J, Duvernois-Berthet E . Improved Genome Editing Efficiency and Flexibility Using Modified Oligonucleotides with TALEN and CRISPR-Cas9 Nucleases. Cell Rep. 2016; 14(9):2263-2272. DOI: 10.1016/j.celrep.2016.02.018. View

13.

Aiuti A, Cattaneo F, Galimberti S, Benninghoff U, Cassani B, Callegaro L . Gene therapy for immunodeficiency due to adenosine deaminase deficiency. N Engl J Med. 2009; 360(5):447-58. DOI: 10.1056/NEJMoa0805817. View

14.

Schnepp B, Chulay J, Ye G, Flotte T, Trapnell B, Johnson P . Recombinant Adeno-Associated Virus Vector Genomes Take the Form of Long-Lived, Transcriptionally Competent Episomes in Human Muscle. Hum Gene Ther. 2015; 27(1):32-42. PMC: 5374867. DOI: 10.1089/hum.2015.136. View

15.

Haeussler M, Schonig K, Eckert H, Eschstruth A, Mianne J, Renaud J . Evaluation of off-target and on-target scoring algorithms and integration into the guide RNA selection tool CRISPOR. Genome Biol. 2016; 17(1):148. PMC: 4934014. DOI: 10.1186/s13059-016-1012-2. View

16.

Teboul L, Murray S, Nolan P . Phenotyping first-generation genome editing mutants: a new standard?. Mamm Genome. 2017; 28(7-8):377-382. PMC: 5569115. DOI: 10.1007/s00335-017-9711-x. View

17.

Doman J, Raguram A, Newby G, Liu D . Evaluation and minimization of Cas9-independent off-target DNA editing by cytosine base editors. Nat Biotechnol. 2020; 38(5):620-628. PMC: 7335424. DOI: 10.1038/s41587-020-0414-6. View

18.

Ott M, Schmidt M, Schwarzwaelder K, Stein S, Siler U, Koehl U . Correction of X-linked chronic granulomatous disease by gene therapy, augmented by insertional activation of MDS1-EVI1, PRDM16 or SETBP1. Nat Med. 2006; 12(4):401-9. DOI: 10.1038/nm1393. View

19.

Sallmyr A, Tomkinson A . Repair of DNA double-strand breaks by mammalian alternative end-joining pathways. J Biol Chem. 2018; 293(27):10536-10546. PMC: 6036210. DOI: 10.1074/jbc.TM117.000375. View

20.

Conrad D, Pinto D, Redon R, Feuk L, Gokcumen O, Zhang Y . Origins and functional impact of copy number variation in the human genome. Nature. 2009; 464(7289):704-12. PMC: 3330748. DOI: 10.1038/nature08516. View